Author + information
- Perwaiz M. Meraj,
- Rajkumar Doshi,
- Bhavitha George,
- Amitkumar Patel,
- Abhishek Vadher and
- Rajiv Jauhar
Background: The benefit of transradial access (TRA) over femoral access (FA) has been demonstrated among various cohorts of patients, however its adoption in the US has been slowly rising. This study aims to demonstrate the benefit of TRA in a real-world acute coronary syndrome cohort.
Methods: 9816 cohorts were analyzed and selected from January 2011- April 2016 from 5 tertiary care centers in New York City. Primary end point was death on discharge and secondary outcomes were myocardial infarction (MI), stroke, tamponade, congestive heart failure (CHF), cardiogenic shock (CS), new dialysis requirement, red blood cell transfusion and bleeding within 72 hours. Data was prospectively collected and retrospectively analyzed.
Results: TRA was associated with a decreased risk of MI, CS, CHF, RBC transfusion, bleeding within 72 hours and death at discharge. Other secondary outcomes were similar between the groups even after performing adjusted analysis.
Conclusions: The adoption of TRA has been slow in the US and in this real-world ACS cohort of patients it is clear that TRA is superior to FA. The centers involved in this registry are all high volume TRA sites. With experience and time all cathlabs should move toward TRA first approach, similar to many countries including India and in Europe.
Poster Hall, Hall C
Saturday, March 18, 2017, 9:45 a.m.-10:30 a.m.
Session Title: Novel Developments in Acute Coronary Syndromes
Abstract Category: 15. Interventional Cardiology: ACS/AMI/Hemodynamics and Pharmacology
Presentation Number: 1194-162
- 2017 American College of Cardiology Foundation